Inicio>>Signaling Pathways>> Others>>N1,N12-Diacetylspermine (hydrochloride)

N1,N12-Diacetylspermine (hydrochloride) (Synonyms: BAS)

Catalog No.GC44283

La N1,N12-diacetilespermina (clorhidrato) es un derivado diacetilado de la espermina. La regulaciÓn al alza de N1,N12-diacetilespermina (clorhidrato) se ha relacionado con la incidencia de cÁncer, lo que la convierte en un biomarcador potencial para la detecciÓn del cÁncer.

Products are for research use only. Not for human use. We do not sell to patients.

N1,N12-Diacetylspermine (hydrochloride) Chemical Structure

Cas No.: 77928-71-3

Tamaño Precio Disponibilidad Cantidad
1mg
94,00 $
Disponible
5mg
425,00 $
Disponible
10mg
754,00 $
Disponible
25mg
1.650,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

N1,N12-Acetylspermine is a diacetylated derivative of spermine , an endogenous polyamine synthesized from spermidine , that displays lower Km and higher Vmax values than spermine, making it a better substrate of polyamine oxidase than the non-acetylated polyamine. Spermine is required for eukaryotic cell growth and protein synthesis and is involved in the modulation of calcium-dependent immune processes. Upregulation of N1,N12-acetylspermine has been linked to the incidence of cancer, making this natural polyamine a potential biomarker for cancer detection.

Reseñas

Review for N1,N12-Diacetylspermine (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N1,N12-Diacetylspermine (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.